title: Pranlukast regulates tumour growth by attenuating IL-4 production in Kimura disease.
authors.affiliation: Department of Paediatrics, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan. yohtsuka@med.juntendo.ac.jp
authors.forename: Yoshikazu
authors.initials: Y
authors.lastname: Ohtsuka
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Shimizu
authors.forename: Tohru
authors.initials: T
authors.lastname: Fujii
authors.forename: Tetsuji
authors.initials: T
authors.lastname: Sato
authors.forename: Masahiro
authors.initials: M
authors.lastname: Saito
authors.forename: Satoru
authors.initials: S
authors.lastname: Nagata
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Takahashi
authors.forename: Yuichiro
authors.initials: Y
authors.lastname: Yamashiro
mesh_terms: D000293:Adolescent; D000796:Angiolymphoid Hyperplasia with Eosinophilia / Q000097:blood / Q000188:drug therapy*; D002648:Child; D002867:Chromones / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D015847:Interleukin-4 / Q000097:blood*; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D008297:Male; D016896:Treatment Outcome
chemical_list: D002867:Chromones; D020024:Leukotriene Antagonists; D015847:Interleukin-4; C047681:pranlukast